AzTrials
AzTrials

Type 1 DiabetesNCT05315037

Resistance Training in Type 1 Diabetes Mellitus

A study testing Resistance Training in people with Type 1 Diabetes, run by University of Louisville at 2 sites in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to learn how different resistance training programs affects blood sugar in young athletes with T1DM. Read more about this study

Who is it for?
Ages 13 to 17 years
Conditions the study is for
Type 1 Diabetes
What is being tested?
Resistance Training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
15 participants
Where
2 sitesUnited States
Study dates
1 Aug 2023to 30 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 13 to 17 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • ≥ 13 years of age
  • ≥2 years from date of T1DM diagnosis
  • Prior exposure to strength and conditioning
  • HbA1C ≤ 10%
  • Actively utilizing continuous glucose monitoring for diabetes management

Who cannot join

  • Physical limitation that may impede ability to complete study procedures
  • Non-English-speaking individual

Trial locations and contacts

2 sites in 1 country.

Brad J Thrasher, DO contact

5025883400

bjthra01@louisville.edu

Sarah P King, BS,BA contact

5026292721

slpenn03@louisville.edu

United States2 sites, 2 recruiting
  • Norton Healthcare

    Louisville, Kentucky, 40202

    Brad J Thrasher, DO, 502-588-3400, bjthra01@louisville.edu

    Sarah P King, BA,BS, 5026292721, slpenn03@louisville.edu

    Recruiting
  • University of Louisville

    Louisville, Kentucky, 40202

    Brad J Thrasher, DO, 502-588-3400, bjthra01@louisville.edu

    Sarah P King, BS,BA, 5026292721, slpenn03@louisville.edu

    Not yet recruiting

Other trials in United States

About this study

Official title: Resistance Training Methods Impact On Glycemic Excursion and Metabolic Pathways in Type 1 Diabetes Mellitus

The purpose of this study is to learn how different resistance training programs affects blood sugar in young athletes with T1DM.

Read the detailed description

Strength and condition training to improve sport performance has been greatly emphasized over the past 20 years. Formal strength and conditioning (S\&C) programming is performed by S\&C coaches who are educated in the field of exercise program with the intentions to bring about particular athletic adaptations through exercise. S\&C programs, previously limited to programs at the college and professional level, are now commonly seen in secondary school athletic programs. With such broad adoption, many athletes that manage chronic diseases, such as type 1 diabetes mellitus, are exposed to elements of these programs.

Diabetes mellitus impacts more than 10% of the United States population. Of these, 5.2% have identified type 1 diabetes mellitus (T1DM) which includes approximately 210,000 individuals under the age of 20. In addition to insulin and dietary management, exercise and physical activity is recommended as an important therapeutic tool for most patients with T1DM. Physical activity has been shown to significantly improve glycemic control in individuals with diabetes. Additional benefits of exercise include improved cardiovascular fitness, muscle strength, insulin sensitivity and blood glucose control. S\&C programs offer benefits to those living with T1DM as different exercises can be tailored to preserve health. However, there are no exercise prescription or guidelines specifically for adolescent athletes diagnosed with type 1 diabetes participating in strength and conditioning programs. Furthermore, there is no available data that states the predictability of glucose response and insulin needs to any of the specific strength and conditioning goals.

Objective: To assess the impact of different strength and conditioning programming on glycemic control in athletes with T1DM.

Primary Aim: Assess glucose response to different resistance training methods. Secondary Aims: To assess for correlation between lactate and glucose using different resistance training methods.

Conditions
Type 1 Diabetes
Keywords
Resistance Training in type 1 diabetes
Medical subject headings
Diabetes Mellitus, Type 1

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Resistance TrainingOther

    Bench press: Exercise performed with participant lying supine with hands in prone position. Barbell is lowered vertically from fully extended elbow position to sternum, then returned to starting position. Barbell will be weighted with plates dependent on their strength and workout demands.

    Deadlift: Consists of gripping bar while in a squat position. Extension of ankles, knees, and hips while gripping the bar brings the weight up until joints are locked completing the exercise concentric portion. The eccentric lowering of the weight follows and consists of flexion of joints.

    Seated overhead press machine: This multi-joint exercise, deltoid and trapezius are the prime movers and triceps are secondary movers, with hands on the grips and a position allowing back and buttocks to be completely supported. They push against a load vertically until glenohumeral joint fully extends, then load is returned to starting position and process continues until all repetitions desired are achieved

Study groups in NCT05315037
Study groupRoleWhat they receive
Resistance TrainingOtherBench press, Deadlift, Seated overhead press machine
Receives: Other: Resistance Training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Assess glucose response to different resistance training methods

    Blood glucose

    Measured: 3 months

Secondary outcomes (1)
  1. To assess for correlation between lactate and glucose using different resistance training methods

    Blood glucose, lactate

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Apr 2022
  2. Study start1 Aug 2023
  3. Primary completion1 Jun 2025 (estimated)
  4. Study completion30 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Model description
Blood glucose and lactate measurements will be collected prior to any physical activity, post workout, and then 10- and 20-minutes post workout. Using a standard lancet device, capillary blood glucose values will be obtained using a Contour Next Glucometer.
Masking
None (open label)
Enrolment
15 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05315037
Sponsor's protocol ID
21.0565
Status last verified
May 2024
First submitted
29 Mar 2022
Last updated
10 May 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Resistance Training in people with Type 1 Diabetes, run by University of Louisville at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 10 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Brad J Thrasher, DO (5025883400, bjthra01@louisville.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Assess glucose response to different resistance training methods (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 May 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in